Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 3
2005 3
2006 3
2007 3
2008 2
2009 5
2010 5
2011 3
2012 1
2013 4
2014 4
2015 1
2016 4
2017 3
2018 4
2019 5
2020 4
2021 7
2022 7
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
Judd S, Revon-Riviere G, Grover SA, Deyell RJ, Vanan MI, Lewis VA, Pecheux L, Zorzi AP, Goudie C, Santiago R, Tran TH, Abbott LS, Brossard J, Moorehead P, Alvi S, Portwine C, Denburg A, Whitlock JA, Cohen-Gogo S, Morgenstern DA. Judd S, et al. Among authors: whitlock ja. Cancer Med. 2024 Feb;13(3):e7033. doi: 10.1002/cam4.7033. Cancer Med. 2024. PMID: 38400668 Free PMC article.
Ensuring access to innovative therapies for children, adolescents, and young adults across Canada: The single patient study experience.
Revon-Riviere G, Young LC, Stephenson EA, Brodeur-Robb K, Cohen-Gogo S, Deyell R, Lacaze-Masmonteil T, Palmer A, Parekh RS, Whitlock JA, Morgenstern DA. Revon-Riviere G, et al. Among authors: whitlock ja. Paediatr Child Health. 2023 Apr 20;28(7):399-403. doi: 10.1093/pch/pxac122. eCollection 2023 Nov. Paediatr Child Health. 2023. PMID: 37885599 Free PMC article. Review.
Developing a partnership to improve health care delivery to children <18 years with cancer and blood disorders in the English-speaking Caribbean: lessons from the SickKids-Caribbean Initiative (SCI).
Reece-Mills M, Bodkyn C, Baxter JB, Allen U, Alexis C, Browne-Farmer C, Craig J, de Young S, Denburg A, Dindial K, Fleming-Carroll B, Gibson T, Gupta S, Knight-Madden J, Manley-Kucey M, Mclean-Salmon S, Ocho ON, Orrigio K, Read S, Sin Quee C, Smith B, Thame M, Wharfe G, Whitlock JA, Zlotkin S, Blanchette V. Reece-Mills M, et al. Among authors: whitlock ja. Lancet Reg Health Am. 2023 Sep 11;26:100592. doi: 10.1016/j.lana.2023.100592. eCollection 2023 Oct. Lancet Reg Health Am. 2023. PMID: 37727865 Free PMC article. Review.
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse.
Hogan LE, Brown PA, Ji L, Xu X, Devidas M, Bhatla T, Borowitz MJ, Raetz EA, Carroll A, Heerema NA, Zugmaier G, Sharon E, Bernhardt MB, Terezakis SA, Gore L, Whitlock JA, Hunger SP, Loh ML. Hogan LE, et al. Among authors: whitlock ja. J Clin Oncol. 2023 Sep 1;41(25):4118-4129. doi: 10.1200/JCO.22.02200. Epub 2023 May 31. J Clin Oncol. 2023. PMID: 37257143 Clinical Trial.
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations.
Villani A, Davidson S, Kanwar N, Lo WW, Li Y, Cohen-Gogo S, Fuligni F, Edward LM, Light N, Layeghifard M, Harripaul R, Waldman L, Gallinger B, Comitani F, Brunga L, Hayes R, Anderson ND, Ramani AK, Yuki KE, Blay S, Johnstone B, Inglese C, Hammad R, Goudie C, Shuen A, Wasserman JD, Venier RE, Eliou M, Lorenti M, Ryan CA, Braga M, Gloven-Brown M, Han J, Montero M, Spatare F, Whitlock JA, Scherer SW, Chun K, Somerville MJ, Hawkins C, Abdelhaleem M, Ramaswamy V, Somers GR, Kyriakopoulou L, Hitzler J, Shago M, Morgenstern DA, Tabori U, Meyn S, Irwin MS, Malkin D, Shlien A. Villani A, et al. Among authors: whitlock ja. Nat Cancer. 2023 Feb;4(2):203-221. doi: 10.1038/s43018-022-00474-y. Epub 2022 Dec 30. Nat Cancer. 2023. PMID: 36585449 Free PMC article.
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
Whitlock JA, Malvar J, Dalla-Pozza L, Goldberg JM, Silverman LB, Ziegler DS, Attarbaschi A, Brown PA, Gardner RA, Gaynon PS, Hutchinson R, Huynh VT, Jeha S, Marcus L, Messinger Y, Schultz KR, Cassar J, Locatelli F, Zwaan CM, Wood BL, Sposto R, Gore L. Whitlock JA, et al. Pediatr Blood Cancer. 2022 Nov;69(11):e29901. doi: 10.1002/pbc.29901. Epub 2022 Aug 21. Pediatr Blood Cancer. 2022. PMID: 35989458
Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial.
Manji A, Samson Y, Deyell RJ, Johnston DL, Lewis VA, Zorzi AP, Berman JN, Brodeur-Robb K, Morrison E, Kee L, Kumar S, Baruchel S, Whitlock JA, Morgenstern DA. Manji A, et al. Among authors: whitlock ja. Cancers (Basel). 2022 Jun 17;14(12):2985. doi: 10.3390/cancers14122985. Cancers (Basel). 2022. PMID: 35740650 Free PMC article.
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001).
Tasian SK, Silverman LB, Whitlock JA, Sposto R, Loftus JP, Schafer ES, Schultz KR, Hutchinson RJ, Gaynon PS, Orgel E, Bateman CM, Cooper TM, Laetsch TW, Sulis ML, Chi YY, Malvar J, Wayne AS, Rheingold SR. Tasian SK, et al. Among authors: whitlock ja. Haematologica. 2022 Oct 1;107(10):2295-2303. doi: 10.3324/haematol.2021.279520. Haematologica. 2022. PMID: 35112552 Free PMC article. Clinical Trial.
72 results